The Comprehensive Guide to Pazopanib 200mg Tablets In the advanced treatment of solid tumors, Pazopanib 200mg Tablets have emerged as a critical targeted therapy. As a leading pharmaceutical exporter from India, Ernest Oncology (a group of Ernest Pharmaceutical Pvt. Ltd.) ensures that this vital medication is available to oncology centers and patients in London, New York, Sydney, Johannesburg, and beyond. Product Specifications Brand Name: Ernest-Oncology (Pazopanib Hydrochloride) Strength: 200 mg per tablet Dosage Form: Oral Film-Coated Tablet Primary Indications: Advanced Renal Cell Carcinoma (RCC) and Advanced Soft Tissue Sarcoma (STS) Storage: Store at room temperature (20°C to 25°C / 68°F to 77°F) Mechanism of Action: How It Works Anti-Angiogenesis: It inhibits Vascular Endothelial Growth Factor Receptors (VEGFR-1, -2, and -3), effectively “starving“ the tumor by preventing the formation of new blood vessels. Signal Disruption: It targets Platelet-Derived Growth Factor Receptors (PDGFR) and Fibroblast Growth Factor Receptors (FGFR), which are involved in cell growth and tumor stability. Inhibiting Proliferation: By blocking c-Kit and other tyrosine kinases, it stops the uncontrolled division of malignant cells.Anti-Angiogenesis: It inhibits Vascular Endothelial Growth Factor Receptors (VEGFR-1, -2, and -3), effectively “starving“ the tumor by preventing the formation of new blood vessels. Signal Disruption: It targets Platelet-Derived Growth Factor Receptors (PDGFR) and Fibroblast Growth Factor Receptors (FGFR), which are involved in cell growth and tumor stability. Inhibiting Proliferation: By blocking c-Kit and other tyrosine kinases, it stops the uncontrolled division of malignant cells. Therapeutic Indications & Administration Advanced Renal Cell Carcinoma (RCC): For patients with advanced kidney cancer. Advanced Soft Tissue Sarcoma (STS): For patients who have received prior chemotherapy. Administration Guidelines:Dosage: The standard recommended adult dose is 800 mg (four 200mg tablets) taken once daily. Food Restrictions: CRITICAL: Pazopanib must be taken on an empty stomach—at least 1 hour before or 2 hours after a meal. Taking it with food can significantly increase absorption to toxic levels. Whole Dose: Tablets should be swallowed whole with water; do not crush or chew them. Clinical Side Effects & Safety Hepatotoxicity: Pazopanib carries a “black box“ warning for severe and potentially fatal liver damage. Regular liver function tests (ALT, AST, and Bilirubin) are mandatory. Hypertension: High blood pressure is very common and must be managed with anti-hypertensive therapy. GI Issues: Diarrhea, nausea, vomiting, and decreased appetite. Cardiac Risks: Potential for QT prolongation (irregular heart rhythm) and cardiac dysfunction. Appearance Changes: Changes in hair color (depigmentation) or skin lightening. Why Source from Ernest Oncology? United Kingdom (London): Providing cost-effective alternatives for NHS and private oncology centers. USA: Supplying bulk quantities that meet stringent safety and documentation benchmarks. Australia: Facilitating access via the “Special Access Scheme“ (SAS) and other regulatory pathways. South Africa: Bridging the gap in cancer care with high-tier pharmaceutical exports from India 📞 Contact Ernest Oncology — Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 📦 Business Type: Exporter | Bulk Supplier | Distributor 🌐 Websites: www.oncologymedicinesupplier.com www.ernestpharmaceuticals.com www.ernestvision.com www.ernestimpex.com 📧 Email: exports@ernestpharmaceuticals.com 📲 WhatsApp: +91 93599 02383 🔗 Direct Link: https://wa.me/919359902383